CHR. HANSEN A/S: Financial statements 2015
CVR: 12516479
Source: annual report 2015, Danish Business Authority
01/09/2014 – 31/08/2015
CHR. HANSEN A/S (CVR 12516479) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 4,250,545,000 and a net result of DKK 1,064,163,000 compared with DKK 911,545,000 the year before. That is an increase of 14.5% compared with the year before. The profit margin was 25%. Equity in the 2015 report amounted to DKK 1,363,788,000. The solvency ratio was 38.2%.
- Revenue
- DKK 4,250,545,000
- Gross Profit
- DKK 2,181,775,000
- Profit/Loss
- DKK 1,064,163,000
- Equity
- DKK 1,363,788,000
- Total Assets
- DKK 3,570,447,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 4.3B | 2.2B | 1.1B | 1.4B | - |
| 2014 | 3.7B | 2B | 911.5M | 1.7B | - |
| 2013 | 3.7B | 2B | 892.9M | 1.1B | - |
Official annual report
How creditworthy is CHR. HANSEN A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 5, 2015, Ditte Marstrand Wulf has stepped down as director of CHR. HANSEN A/S.
As of August 1, 2015, Søren Westh Lonning has joined the board of directors of CHR. HANSEN A/S.
As of August 1, 2015, Klaus Pedersen has left the board of directors of CHR. HANSEN A/S.
As of August 1, 2015, Ditte Marstrand Wulf is registered as director of CHR. HANSEN A/S.
As of August 1, 2015, Jesper Preben Allentoft has stepped down as director of CHR. HANSEN A/S.
About CHR. HANSEN A/S
CHR. HANSEN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1988. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named CHR. HANSEN'S LABORATORIUM DANMARK A/S and A/S PSE NR. 2770. The management consists of Morten Enggaard Rasmussen. The board consists of Rainer Chapour Lehmann (chair), Anders Lund, Helle Rexen and Lisbet Kragelund. The company is owned by NOVOZYMES A/S. The company has 1,747 employees (2026). In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. Equity in the 2025 report amounted to DKK 11,263,718,000.